Ultime notizie per Statera BioPharma (OTC:STAB) Azioni

Statera BioPharma

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

STATERA BIOPHARMA INC by Statera Biopharma, Inc.

Statera BioPharma Inc

Stabilis Solutions Inc

Stabilus SE

StableXSwap

Stably USD - True USD

Sterling Infrastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRL#NASDAQ">STRL</a>) raises FY2025 Adj EPS guidance from $7.90-$8.40 to $8.40-$8.90 vs $7.27 analyst estimate. Raises FY2025 sales outlook from $2.00 billion-$2.15 billion to $2.05 billion-$2.15 billion vs $2.02 billion estimate.

News

Guidance

STRL

CORRECTION: Sterling Infrastructure Raises FY2025 Adj EPS Guidance from $7.90-$8.40 to $8.40-$8.90 vs $7.27 Est; Raises FY2025 Sales Guidance from $2.00B-$2.15B to $2.05B-$2.15B vs $2.02B Est

Home Depot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) has outperformed the market over the past 10 years by 2.01% on an annualized basis producing an average annual return of 12.39%. Currently, Home Depot has a market capitalization of $359.57 billion. 
Buying $1000 In HD: If an investor had bought $1000 of HD stock 10 years ago, it would be worth $3,232.62 today based on a price of $361.73 for HD at the time of writing.
<h3>Home Depot's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746479725_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Home Depot Stock In The Last 10 Years

Timbercreek Financial (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TF#TSX">TF</a>) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.16 by 18.75 percent. This is a 11.76 percent increase over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $28.57 million which beat the analyst consensus estimate of $27.07 million by 5.55 percent. This is a 16.20 percent increase over sales of $24.59 million the same period last year.

Earnings

Earnings Beats

TSX:TF

Timbercreek Financial Q1 Adj. EPS $0.19 Beats $0.16 Estimate, Sales $28.57M Beat $27.07M Estimate

Today the company's board of directors appointed William C. Whitaker, vice president, finance, and director, investor relations, to serve as the company's interim chief financial officer until the board concludes its review process. &nbsp;

Management

Ashland Appoints William C. Whitaker, Vice President, Finance, And Director, Investor Relations, To Serve As The Company's Interim CFO Until The Board Concludes Its Review Process

&nbsp;(All dollar amounts are expressed in Canadian dollars, unless otherwise noted.)
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Kinross Gold Corporation ("Kinross" or the "Company") (TSX:<a class="ticker" href="https://www.benzinga.com/stock/K#TSX">K</a>, NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGC#NYSE">KGC</a>) announced today that it has acquired an aggregate of 7,574,237 units (each, a "Unit") of Eminent Gold Corp. ("Eminent") at a price of $0.40 per Unit and an aggregate purchase price of $3,029,694.80 (the "Acquisition"), pursuant to the closing of a private placement by Eminent of 10,711,900 Units. Each Unit consisted of one common share in the capital of Eminent (each, a "Share") and one-half of one Share purchase warrant (each whole warrant being a "Warrant"). Each Warrant shall entitle the holder thereof to acquire one Share at an exercise price of $0.70 per Share for a period of 24 months from their issuance.
Prior to the Acquisition, Kinross did not own or have control over any securities of Eminent. As a result of the Acquisition, Kinross acquired an aggregate of 7,574,237 Shares and 3,787,118 Warrants, representing approximately 9.9% of the issued and outstanding Shares on a non-diluted basis and 14.15% of the issued and outstanding Shares on a partially diluted basis.

TSX:K

Kinross Gold Acquires 7.57M Units Of Eminent Gold For C$3.03M In Private Placement Deal, Gaining Shares And Warrants With 2-Year Option To Purchase Additional Stock At C$0.70 Per Share

Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) released its third-quarter results after Monday's closing bell. Here's a look at the key figures<a href="https://www.benzinga.com/pressreleases/25/05/n45206776/clorox-reports-q3-fiscal-year-2025-results-updates-outlook"> from the report.&nbsp;</a>
The Details:&nbsp;Clorox reported quarterly earnings of $1.45 per share, which missed the analyst consensus estimate of $1.57. Quarterly revenue came in at $1.67 billion, which missed the analyst consensus estimate of $1.73 billion and is down from revenue of $1.81 billion from the same period last year.
Read Next: <a href="https://www.benzinga.com/news/earnings/25/05/45194998/saudi-arabias-oil-power-play-jolts-markets-can-diamondback-and-rivals-survive-the-squeeze?utm_source=articleShare">Saudi Arabia&#8217;s Oil Power Play Jolts Markets: Can Diamondback And Rivals Survive The Squeeze?</a>
The company reported gross margin&nbsp;increased 240 basis points to 44.6% from 42.2% in the year-ago quarter, primarily driven by cost savings and the benefits from the divestitures of the VMS and&nbsp;Argentina&nbsp;businesses.
&#8220;In the third quarter, heightened macroeconomic uncertainties drove changes in shopping behaviors, resulting in temporary category slowdowns and lower sales. We expect these slowdowns to persist in the fourth quarter, as reflected in our updated outlook,&#8221; said CEO&nbsp;Linda Rendle.&nbsp;
Outlook:&nbsp;Clorox affirmed its fiscal 2025 adjusted EPS guidance of&nbsp;$6.95 to $7.35&nbsp;per share, versus the $7.12&nbsp;analyst estimate. The company narrowed its fiscal year revenue outlook from a range of&nbsp;$7.02 billion to $7.24 billion&nbsp;to&nbsp;a range of $7.02 billion to $7.09 billion, below the $7.1 billion&nbsp;estimate.
CLX Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Clorox stock was down 4.06% after-hours at $132.77 on Monday.  
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/management/25/05/45180224/these-ev-makers-could-shine-if-musk-leaves-tesla?utm_source=articleShare">These EV Makers Could Shine If Musk Leaves Tesla</a></li>
</ul>
Image: Shutterstock

Movers

Clorox Stock Drops After Worse-Than-Expected Q3 Results: 'Heightened Macroeconomic Uncertainties' Lowered Sales, CEO says

BTB REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BTB#TSX">BTB</a>) reported quarterly earnings of $0.10 per share. This is a 15.73 percent increase over earnings of $0.09 per share from the same period last year. The company reported $34.41 million in sales this quarter. This is a 5.44 percent increase over sales of $32.64 million the same period last year.

TSX:BTB

BTB REIT Q1 FFO $0.10 Up From $0.09 YoY, Sales $34.41M Up From $32.64M YoY

Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>) lowers FY2025 FFO guidance from $6.82-$7.06 to $6.43-$6.63 vs $6.42 analyst estimate..

Sun Communities Lowers FY2025 FFO Guidance From $6.82-$7.06 To $6.43-$6.63 Vs $6.42 Est

Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>) is looking for Q2 FFO of $1.62-$1.70 vs $1.74 analyst estimate..

Sun Communities Sees Q2 FFO $1.62-$1.70 vs $1.74 Est

UBS analyst Kevin Caliendo maintains Envista Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVST#NYSE">NVST</a>) with a Neutral and lowers the price target from $21 to $18.

Price Target

Analyst Ratings

NVST

UBS Maintains Neutral on Envista Holdings, Lowers Price Target to $18

Ashland's Senior Vice President And Chief Financial Officer Kevin Willis To Depart From The Company, Effective May 16th

Ero Copper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ERO#NYSE">ERO</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.20 by 75 percent. This is a 118.75 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $125.10 million which missed the analyst consensus estimate of $128.70 million by 2.80 percent. This is a 18.24 percent increase over sales of $105.80 million the same period last year.

Earnings Misses

Ero Copper Q1 Adj. EPS $0.35 Beats $0.20 Estimate, Sales $125.10M Miss $128.70M Estimate

Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $1.14 by 10.53 percent. This is a 5.88 percent increase over earnings of $1.19 per share from the same period last year. The company reported $470.20 million in sales this quarter. This is a 0.21 percent increase over sales of $469.20 million the same period last year.

Sun Communities Q1 FFO $1.26 Beats $1.14 Estimate, Sales $470.20M Up From $469.20M YoY

UBS analyst A.J. Rice maintains BXP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXP#NYSE">BXP</a>) with a Neutral and lowers the price target from $80 to $68.

UBS Maintains Neutral on BXP, Lowers Price Target to $68

General

CALX

Calix Reveals That United Fiber Achieved A 25% Surge In Sales And A 10% Acquisition-Related Lift In Average Revenue Per User Within A Single Month By Making The Award-Winning Smartbiz The Centerpiece Of Their Small Business Go-To-market Strategy

The Company's Board of Directors also approved a quarterly distribution increase of 10.6%, to $1.04 per common share and unit. The increase is expected to begin with the second quarter distribution that is anticipated to be paid in July 2025. While the Board of Directors has approved the new quarterly distribution policy, the amount of each quarterly distribution on the Company's common stock will be subject to approval by the Board of Directors.

Dividends

Sun Communities Increases Quarterly Dividend From $0.94 To $1.04 Per Share

JP Morgan analyst David Karnovsky reiterated an Overweight rating on the shares of Cinemark Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNK#NYSE">CNK</a>) on Monday and raised the price forecast from $34.00 to $35.00.
Cinemark's <a href="https://www.benzinga.com/news/earnings/25/05/45169195/whats-going-on-with-cinemark-stock-today">first-quarter performance</a> topped expectations, delivering $541 million in revenue and $36 million in adjusted EBITDA, ahead of consensus estimates of $524 million and $34 million, respectively. 
Compared to the analyst&#8217;s forecast of $515 million in revenue and $26 million in EBITDA, the outperformance was driven across key metrics, including higher attendance, improved per-patron spending, and additional revenue streams. 
On the expense side, results were mostly aligned with forecasts, though concession costs came in above projections. Management attributed this to a higher mix of merchandise in what is typically a lighter quarter, with costs expected to normalize going forward.
Also Read: <a href="https://www.benzinga.com/25/05/45175845/wall-street-reacts-as-airbnb-eyes-growth-amid-us-slowdown-details">Wall Street Reacts As Airbnb Eyes Growth Amid US Slowdown</a>
Looking ahead, the company increased its 2025 wide-release film forecast to 120, up from 115, matching the analyst&#8217;s current projection. 
Cinemark also expressed greater optimism for 2026, spotlighting Amazon MGM's CinemaCon participation and its potential to debut as many as 14 films in theaters that year, compared to just four expected in 2025. 
On broader economic trends, Cinemark reiterated that box office demand had shown little historical sensitivity to economic conditions and reported no noticeable impact on per-capita spending or premium large-format attendance.
The 2025 North American box office forecast has been revised upward to $9.523 billion, marking an 11.1% year-over-year increase, driven by stronger-than-expected second-quarter projections.
Karnovsky&#8217;s projections for 2025 have been updated, with revenue now expected to reach $3.374 billion and adjusted EBITDA forecast at $674 million.
The outlook reflects a 6.4% rise in domestic theater attendance and a 3% bump in ticket prices, slightly reducing market share to 14.2%. 
Karnovsky noted that the second quarter is anticipated to see a 14.4% market share, pressured by competition from Inside Out 2 and capacity constraints, though partially offset by a strong lineup of family and horror titles.
Price Action: CNK shares traded lower by 3.53% at $29.23 at last check on Monday.
Read Next: <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45199697/whats-going-on-with-lucid-group-stock-on-monday">What&#8217;s Going On With Lucid Group Stock On Monday?</a>
Photo: Shutterstock

Reiteration

Box Office Momentum Pushes Cinemark Past Forecasts, Says Analyst

CT Real Est IT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CRT#TSX">CRT</a>) reported quarterly earnings of $0.32 per share. This is a 3.9 percent increase over earnings of $0.31 per share from the same period last year. The company reported $150.40 million in sales this quarter. This is a 4.28 percent increase over sales of $144.22 million the same period last year.

TSX:CRT

CT Real Est IT Q1 FFO $0.32 Up From $0.31 YoY, Sales $150.40M Up From $144.22M YoY

Stock Repurchase Program
The Company's Board of Directors has authorized a stock repurchase program of up to $1.0&nbsp;billion of the Company's outstanding common stock. The stock repurchase program does not obligate the Company to acquire any particular amount of common stock, and the repurchase program may be suspended or discontinued at any time at the Company's discretion, through the expiration date of April 30, 2026.

Buybacks

Sun Communities Has Authorized A Stock Repurchase Program Of Up To $1B Of Outstanding Common Stock

<h3>Gainers</h3>
<ul>
<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares increased by 49.5% to $0.27 during Monday's after-market session. The market value of their outstanding shares is at $3.8 million. </li>
<li>iOThree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOTR#NASDAQ">IOTR</a>) shares increased by 6.12% to $0.42. The company's market cap stands at $10.7 million. </li>
<li>TNL Mediagene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNMG#NASDAQ">TNMG</a>) shares increased by 5.99% to $0.32. The company's market cap stands at $8.3 million. The company's, FY earnings came out 2 days ago. </li>
<li>TrueCar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUE#NASDAQ">TRUE</a>) shares increased by 5.08% to $1.55. The market value of their outstanding shares is at $135.2 million. As per the news, the Q1 earnings report came out today. </li>
<li>Yalla Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YALA#NYSE">YALA</a>) shares increased by 4.83% to $7.37. The company's market cap stands at $1.1 billion. </li>
<li>Treasure Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) stock rose 4.56% to $2.06. The company's market cap stands at $3.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>PLAYSTUDIOS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYPS#NASDAQ">MYPS</a>) shares declined by 7.2% to $1.3 during Monday's after-market session. The company's market cap stands at $163.1 million. As per the news, the Q1 earnings report came out today. </li>
<li>Brag House Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBH#NASDAQ">TBH</a>) shares decreased by 7.13% to $0.58. The company's market cap stands at $6.1 million. </li>
<li>Fangdd Network Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUO#NASDAQ">DUO</a>) shares declined by 6.67% to $0.22. The market value of their outstanding shares is at $10.8 million. </li>
<li>LZ Technology Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) shares declined by 5.91% to $9.4. The market value of their outstanding shares is at $1.4 billion. </li>
<li>LiveOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVO#NASDAQ">LVO</a>) shares fell 5.0% to $0.66. The company's market cap stands at $62.9 million. </li>
<li>Intelligent Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTJ#NASDAQ">INTJ</a>) shares declined by 4.96% to $0.55. The market value of their outstanding shares is at $7.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Statera BioPharma

Notizie

Ultime notizie per Statera BioPharma (OTC:STAB) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO